• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白尿在临床研究中的作用:针对每一个旧答案,提出一个新的关键问题。

[Role of proteinuria in clinical research: for each old-answer, a new key-question.].

作者信息

Provenzano Michele, Garofalo Carlo, Chiodini Paolo, Mancuso Cinzia, Barbato Eliana, De Nicola Luca, Andreucci Michele

机构信息

Dipartimento di Nefrologia, Università Magna Graecia, Catanzaro.

Dipartimento di Nefrologia, Università della Campania Luigi Vanvitelli, Napoli.

出版信息

Recenti Prog Med. 2020 Feb;111(2):74-81. doi: 10.1701/3309.32797.

DOI:10.1701/3309.32797
PMID:32089556
Abstract

The presence of proteinuria, i.e. an abnormal amount of proteins in the urine is a well documented cardiovascular (CV) and renal risk factor either in the general population or in high-risk populations such as patients with type 2 diabetes, previous CV disease and patients under regular nephrology care. Indeed, the increase in proteinuria levels, even if of small entity, is associated to a faster decline in renal function over time, increased risk of End-Stage-Kidney-Disease and CV mortality. The deleterious effect of proteinuria on the kidney is attributable to the primitive glomerular damage as well as to the direct toxicity the proteinuria exerts on the tubule-interstitium. In addition, the more general association with the increased CV risk can be explained by the evidence that proteinuria can be considered a marker of systemic and renal endothelial damage. A reduction in proteinuria over time (a 30% decrease after 6 months of treatment in proteinuria is considered acceptable) as response to antihypertensive or antiproteinuric drugs protects against the development of all mentioned endpoints. Further studies are needed to better clarify: what is the normal value of proteinuria excretion, how many measures should be done during follow-up to truely assess the risk of future outcomes, what is the exact prognostic role of proteinuria.

摘要

蛋白尿的存在,即尿液中蛋白质含量异常,在普通人群或高危人群(如2型糖尿病患者、既往有心血管疾病的患者以及接受常规肾病护理的患者)中,是一个有充分文献记载的心血管(CV)和肾脏危险因素。事实上,蛋白尿水平的升高,即使幅度较小,也与肾功能随时间的更快下降、终末期肾病风险增加和心血管死亡率增加相关。蛋白尿对肾脏的有害作用可归因于原发性肾小球损伤以及蛋白尿对肾小管间质的直接毒性。此外,蛋白尿与心血管风险增加的更普遍关联可以通过以下证据来解释:蛋白尿可被视为全身和肾脏内皮损伤的标志物。随着时间的推移,蛋白尿减少(治疗6个月后蛋白尿减少30%被认为是可接受的)作为对抗高血压或抗蛋白尿药物的反应,可预防所有上述终点事件的发生。需要进一步研究以更好地阐明:蛋白尿排泄的正常值是多少,随访期间应进行多少次测量才能真正评估未来结局的风险,蛋白尿的确切预后作用是什么。

相似文献

1
[Role of proteinuria in clinical research: for each old-answer, a new key-question.].蛋白尿在临床研究中的作用:针对每一个旧答案,提出一个新的关键问题。
Recenti Prog Med. 2020 Feb;111(2):74-81. doi: 10.1701/3309.32797.
2
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.高血压患者的亚临床肾损伤:打开一扇观察心血管系统的肾脏之窗。聚焦微量白蛋白尿。
Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85.
3
Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.蛋白尿的心血管影响:慢性肾脏病的一个指标。
Nat Rev Cardiol. 2009 Apr;6(4):301-11. doi: 10.1038/nrcardio.2009.11.
4
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.糖尿病慢性肾脏病患者残留蛋白尿水平的心脏肾脏预后:四项队列研究的汇总分析。
Nephrol Dial Transplant. 2018 Nov 1;33(11):1942-1949. doi: 10.1093/ndt/gfy032.
5
Proteinuria: natural course, prognostic implications and therapeutic considerations.蛋白尿:自然病程、预后意义及治疗考量
Minerva Med. 2007 Dec;98(6):693-711.
6
Time to abandon microalbuminuria?是时候摒弃微量白蛋白尿了吗?
Kidney Int. 2006 Oct;70(7):1214-22. doi: 10.1038/sj.ki.5001729. Epub 2006 Jul 26.
7
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.蛋白尿 2 型糖尿病和肾病患者发生终末期肾病与心血管死亡率的相对发生率:来自 DIAMETRIC(糖尿病肾脏并发症防治研究联盟)数据库的结果。
Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.
8
Proteinuria: its clinical importance and role in progressive renal disease.
Am J Kidney Dis. 2000 Apr;35(4 Suppl 1):S97-105. doi: 10.1016/s0272-6386(00)70237-x.
9
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.蛋白尿作为非糖尿病肾病进展的一个可改变的危险因素。
Kidney Int. 2001 Sep;60(3):1131-40. doi: 10.1046/j.1523-1755.2001.0600031131.x.
10
Proteinuria: an underappreciated risk factor in cardiovascular disease.蛋白尿:心血管疾病中一个未被充分认识的危险因素。
Curr Cardiol Rep. 2002 Nov;4(6):458-62. doi: 10.1007/s11886-002-0106-5.

引用本文的文献

1
Low-dose lipopolysaccharide inducing continuous and obvious increase in urinary protein in hyperglycemic rats and the underlying mechanism.低剂量脂多糖诱导高血糖大鼠持续明显尿蛋白增加及其机制。
PLoS One. 2023 Jul 19;18(7):e0288876. doi: 10.1371/journal.pone.0288876. eCollection 2023.
2
Focus on the Prevention of Acute Limb Ischemia: Centrality of the General Practitioner from the Point of View of the Internist.关注急性肢体缺血的预防:从内科医生角度看全科医生的核心地位
J Clin Med. 2023 May 24;12(11):3652. doi: 10.3390/jcm12113652.
3
Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease.
基线临床变量对糖尿病肾病中SGLT2抑制剂抗蛋白尿作用的影响。
Life (Basel). 2023 Apr 21;13(4):1061. doi: 10.3390/life13041061.
4
Up-Date on Diabetic Nephropathy.糖尿病肾病的最新进展
Life (Basel). 2022 Aug 8;12(8):1202. doi: 10.3390/life12081202.
5
Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease.精准肾脏医学在糖尿病与慢性肾脏病患者中的应用。
Int J Mol Sci. 2022 May 20;23(10):5719. doi: 10.3390/ijms23105719.
6
Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD).社论:非透析依赖型慢性肾脏病(ND-CKD)患者的管理
Front Med (Lausanne). 2022 Feb 3;8:827245. doi: 10.3389/fmed.2021.827245. eCollection 2021.
7
OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction.《慢性肾脏病中的组学研究:聚焦预后与预测》。
Int J Mol Sci. 2021 Dec 29;23(1):336. doi: 10.3390/ijms23010336.
8
Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: "Can the Promise Be Kept?".缺氧诱导因子稳定剂在终末期肾病中的应用:“承诺能否兑现?”。
Int J Mol Sci. 2021 Nov 22;22(22):12590. doi: 10.3390/ijms222212590.
9
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report.腹股沟疝与动脉疾病之间的关联:初步报告。
Biology (Basel). 2021 Aug 1;10(8):736. doi: 10.3390/biology10080736.
10
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization.慢性肾脏病对外周动脉疾病和外周血管重建的影响。
Int J Gen Med. 2021 Jul 23;14:3749-3759. doi: 10.2147/IJGM.S322417. eCollection 2021.